A detailed history of Elequin Capital LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Elequin Capital LP holds 128 shares of SRPT stock, worth $15,603. This represents 0.01% of its overall portfolio holdings.

Number of Shares
128
Holding current value
$15,603
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$124.33 - $156.75 $15,914 - $20,064
128 New
128 $15,000
Q2 2023

Aug 14, 2023

BUY
$106.4 - $157.19 $18,939 - $27,979
178 Added 1618.18%
189 $21,000
Q1 2023

May 11, 2023

BUY
$117.53 - $155.99 $1,292 - $1,715
11 New
11 $1,000
Q2 2022

Aug 11, 2022

BUY
$62.69 - $88.44 $1,379 - $1,945
22 Added 7.12%
331 $25,000
Q1 2022

May 16, 2022

BUY
$63.15 - $90.42 $19,513 - $27,939
309 New
309 $24,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.7B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Elequin Capital LP Portfolio

Follow Elequin Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Elequin Capital LP with notifications on news.